Carbon-11 Precursor for Stereoselective Amino Acid Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The synthesis of carbon-11-labeled amino acids for use in positron emission tomography (PET) is hindered by the need for stereoselective reactions and time-consuming chiral separation, which limits the availability and practicality of these radiopharmaceuticals due to the short half-life of carbon-11 and the complexity of achieving enantiomeric purity.

Innovation Solution

A precursor compound of formula I, which allows for diastereoselective labeling with carbon-11 and subsequent enantioselective production of amino acids by eliminating a chiral auxiliary, enabling the rapid synthesis of either L- or D-α-amino acids and their derivatives with high radiochemical yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to synthesize carbon-11-labeled amino acids, then the synthesis can be completed, but the process requires time-consuming chiral separation via HPLC and achieves limited enantiomeric purity

Engineering Contradiction:
Improveenantiomeric purityVSAvoidsynthesis time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The invention applies preliminary action by incorporating a chiral auxiliary (such as a sulfinyl group) into the precursor molecule before the carbon-11 labeling step. This pre-installed chiral information guides the subsequent labeling reaction to proceed with high diastereoselectivity, eliminating the need for time-consuming post-synthesis chiral separation via HPLC and achieving enantiomeric purity directly from the synthesis process

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The chiral auxiliary serves as an intermediary element that temporarily modifies the precursor structure to enable stereoselective carbon-11 incorporation. This intermediary group creates a diastereomeric relationship during the labeling reaction, allowing one enantiomer to be formed preferentially, and can be removed afterward to yield the desired enantiomerically pure amino acid

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If stereoselective reactions are employed to achieve enantiomeric purity, then the desired optical purity is obtained, but the process complexity increases and radiochemical yield decreases

Engineering Contradiction:
Improveenantiomeric purityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention applies parameter changes by modifying the chemical environment and reaction conditions through the introduction of a chiral auxiliary group. This changes the steric and electronic parameters of the precursor, creating a diastereomeric transition state that favors one enantiomer during carbon-11 labeling. The auxiliary group can be systematically varied (e.g., different sulfinyl groups) to optimize both selectivity and reaction efficiency, simplifying the overall process

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If conventional labeling methods are used, then carbon-11 incorporation is achieved, but the specific activity and radiochemical yield are limited by synthesis time

Engineering Contradiction:
Improveradiochemical yieldVSAvoidsynthesis time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The chiral auxiliary enables preliminary organization of the precursor structure that facilitates rapid and efficient carbon-11 incorporation. By pre-establishing the diastereomeric framework, the labeling reaction proceeds with higher rate and efficiency, maximizing radiochemical yield within the limited half-life window of carbon-11 (20.4 minutes) without requiring extended reaction or separation times

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the efficient production of enantiomerically pure carbon-11-labeled amino acids within 20 minutes, overcoming the limitations of previous methods by achieving high stereoselectivity and radiochemical yield, thus enhancing the applicability of PET radiotracers.

Implementation Method 1

The precursor according to the invention enables diastereoselective labeling with a carbon-11 synthon, i.e., a diastereomer is preferably obtained

Methodology Applied
Scientific EffectDiastereoselective reaction: Chemical Bonding

Implementation Method 2

the labeling reaction, which is known in particular as a nucleophilic addition

Methodology Applied
Scientific EffectNucleophilic addition: Chemical Bonding

Implementation Method 3

subsequently to hydrolysis, which releases the desired product

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentEP3621941B1Use of precursors for the production of carbon-11-labelled amino acids and derivatives thereof
Publication Date: 2021.10.06 ABX ADVANCED BIOCHEM COMPOUNDS GMBH
  • EP3621941B1 patent drawingFigure 1
  • EP3621941B1 patent drawingFigure 2
  • EP3621941B1 patent drawingFigure 3

AI summary

The invention relates to the use of a precursor for the production of carbon-11-labelled amino acids or derivatives thereof. According to the invention, the precursor is a compound of formula I: (formula I), where R1 and R2 are selected independently of one another from the group comprising hydrogen, unsubstituted or substituted C1-C6 alkyl, which optionally can be modified by incorporation of at least one group X in the carbon chain, unsubstituted or substituted C2-C6 alkenyl, which optionally can be modified by incorporation of at least one group X in the carbon chain, substituted or unsubstituted alkylaryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R3 is a chiral auxiliary selected from the group comprising substituted or unsubstituted C1-C6 alkylsulfinyl, substituted or unsubstituted arylsulfinyl, substituted or unsubstituted arylalkyl, and substituted or unsubstituted arylglycinol; X is selected from the group comprising oxygen, sulphur, -SO-, -SO2- and -N(R10)-; R10 comprises hydrogen, unsubstituted or substituted C1-C6 alkyl, unsubstituted or substituted C2-C6 alkenyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, and the groups are optionally unprotected or protected.